Promotion
NEW PLATFORM WILL BENEFIT PHARMACY BUYERS
The Cambrian Alliance Group has recently launched e-CASS market, a new platform designed to enable pharmacy contractors to buy and sell stock from each other with ease.
T
he new platform is set to transform the way that contractors manage their surplus stock and also provide a vital new channel
for contractors to source stock that may be in short supply via traditional methods. ‘e-CASS is already the most widely used buying platform across independent pharmacy and this new additional platform continues to strengthen the Cambrian Alliance Group offer,’ said Nathan Wiltshire, the Group’s CEO.
Cambrian Alliance Group boasts a membership of over 1200 members across the UK. The group supports its members in achieving better purchasing margins by leveraging the buying power of its collective membership, which now exceeds £0.6Bn annually.
The group claims that what is commonly
referred to as ‘dead stock’ costs the average pharmacy approximately £12K per year: a significant cost at a time when independent
The new platform includes an industry first ‘market match’ feature available to buyers, which matches all available stock in the market to
pharmacy has never been under more pressure to maintain margin. e-CASS market will allow contractors to list stock and make it available to buy to a chosen and specified group of buyers, or to the entire Cambrian Alliance Group membership of 1200.
‘We are really pleased to be able to bring yet another new product to the independent pharmacy market,’ Wiltshire continued.
‘When we first launched e-CASS some ten years ago, it revolutionised the way that pharmacy thought about purchasing and delivered immediate benefits to our user community. We believe that e-CASS market will have a similar impact.’
buyers’ specific requirements, based upon their most recent product usages.
The platform also ensures that buyers get notified every time relevant stock becomes available.
Use of the platform meets with current MHRA guidance with regard to the implications of the repeal of Section 10(7) for the supply of licensed medicines by pharmacy in that transactions are on a small and occasional basis, and not for profit.
‘The new platform gives contractors a vital alternative to supply at a time when product shortages and availability have never been more prevalent,’ Wiltshire added.
‘In addition, we are pleased to be able to provide the market with a new tool that really enables contractors to help and support each other at such a challenging time.’
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
